VIVO Cannabis(TM) Adds Craft Licensed Producer, Delta 9 to Online Medical Marketplace

Toronto, Ontario--(Newsfile Corp. - October 6, 2021) - VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) ("VIVO" or the "Company"), a leading provider of premium cannabis products and services, and holder of licenses under the Cannabis Act through its wholly-owned subsidiaries, Canna Farms Limited ("Canna Farms") and ABcann Medicinals Inc. ("ABcann"), today announced a partnership with Delta 9 Cannabis Inc ("Delta 9") to offer Delta 9 products on VIVO's Canna Farms e-commerce marketplace.

VIVO and Delta 9 are two of Canada's longest running cannabis companies, both receiving Health Canada licenses late 2013 to early 2014. Through the Delta 9 and VIVO supply partnership, VIVO will purchase and list a selection of Delta 9 cannabis dried flower products for sale directly to Canna Farms' medical patients, expanding its portfolio offering of brand options for nearly 20,000 active medical patients.

"We're pleased to add Delta 9 as a new LP supply partner," commented Ray Laflamme, Canna Farms' Co-Founder and VIVO Chief Executive Officer. "As the leader in the health & wellness cannabis industry, we are committed to providing our patients with access to quality craft cannabis."

"We're excited for our craft products to be available nationally through one of the leading medical cannabis marketplaces," commented John Arbuthnot, Delta 9's Founder and Chief Executive Officer. "Delta 9's small batch, hand trimmed strains, are complementary to Canna Farms' craft product offerings."

In addition to the Company's Canna Farms™, Beacon Medical™, Fireside™ brands and products, Delta 9 joins existing third-party partners to provide a broad selection of medical cannabis products and accessories in one convenient medical marketplace for patients.

Patients requiring support with registration or placing orders may contact VIVO's Customer Care Team at 1 (855) 882-0988 or [email protected].

About Delta 9 Cannabis Inc.

Delta 9 Cannabis Inc. is a vertically integrated cannabis company focused on bringing the highest quality cannabis products to market. The Company sells cannabis products through its wholesale and retail sales channels and sells its cannabis grow pods to other businesses. Delta 9's wholly-owned subsidiary, Delta 9 Bio-Tech Inc., is a licensed producer of medical and recreational cannabis and operates an 80,000 square foot production facility in Winnipeg, Manitoba, Canada. Delta 9 owns and operates a chain of retail stores under the Delta 9 Cannabis Store brand. Delta 9's shares trade on the Toronto Stock Exchange under the symbol "DN" and on the OTCQX under the symbol "DLTNF". For more information, please visit www.delta9.ca.

About VIVO Cannabis™

VIVO Cannabis™ is recognized for trusted, premium cannabis products and services. It holds production and sales licences from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms™, Beacon Medical™, Fireside™, and Lumina™. Harvest Medicine™, VIVO's patient-centric, scalable network of medical cannabis clinics, has serviced over 150,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. For more information visit: www.vivocannabis.com.

For further information:
VIVO Investor Relations
+1 416-848-9839
[email protected]

Instagram: https://www.instagram.com/vivo_cannabis/
Facebook: https://www.facebook.com/vivocanna/
Twitter: https://twitter.com/vivo_cannabis
LinkedIn: https://www.linkedin.com/company/vivo-cannabis-inc/

Disclaimer for Forward-Looking Information

Certain statements in this news release are forward-looking statements, which are statements that are not purely historical, including statements regarding the beliefs, plans, expectations or intentions of VIVO and its management regarding the future. Forward-looking statements in this news release include statements regarding: the launch of Delta 9 flower on the Company's e-commerce marketplace. Such statements are subject to risks and uncertainties that may cause actual results, performance or developments to differ materially from those contained in the forward‐looking statements, including: that the launch of Delta 9 flower on the Company's e-commerce marketplace. No assurance can be given that any of the events anticipated by the forward‐looking statements will occur or, if they do occur, what benefits the Company will obtain from them. Readers are urged to consider these factors carefully, and the more extensive risk factors included in the Company's management's discussion and analysis for the three months ended June 30, 2021, available on SEDAR, in evaluating the forward‐looking statements contained in this news release and are cautioned not to place undue reliance on such forward‐looking statements, which are qualified in their entirety by these cautionary statements. The forward‐looking statements in this news release are made as of the date hereof and the Company disclaims any intent or obligation to update publicly any such forward‐looking statements, whether as a result of new information, future events or results or otherwise, except as required by applicable securities laws.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/98774